126 related articles for article (PubMed ID: 6795373)
21. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF
Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182
[No Abstract] [Full Text] [Related]
22. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
[No Abstract] [Full Text] [Related]
23. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
Döring G; Goldstein W; Röll A; Schiøtz PO; Høiby N; Botzenhart K
Infect Immun; 1985 Sep; 49(3):557-62. PubMed ID: 3928491
[TBL] [Abstract][Full Text] [Related]
24. Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies.
Rao AR; Splaingard MS; Gershan WM; Havens PL; Thill A; Barbieri JT
Pediatr Pulmonol; 2005 May; 39(5):402-7. PubMed ID: 15666370
[TBL] [Abstract][Full Text] [Related]
25. Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.
Grzybowski J; Trafny EA; Wrembel-Wargocka J; Patzer J; Dzierzanowska D; Zawistowska-Marciniak I; Kłos M
J Clin Microbiol; 1989 Jun; 27(6):1367-71. PubMed ID: 2502560
[TBL] [Abstract][Full Text] [Related]
26. Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients.
Crowe KE; Bass JA; Young VM; Straus DC
J Clin Microbiol; 1982 Jan; 15(1):115-22. PubMed ID: 6821202
[TBL] [Abstract][Full Text] [Related]
27. Passive hemagglutination reaction using formalinized sheep erythrocytes treated with tannic acid and coated with exotoxin of Pseudomonas aeruginosa.
Takeshi K; Homma JY
Jpn J Exp Med; 1978 Dec; 48(6):497-501. PubMed ID: 108439
[TBL] [Abstract][Full Text] [Related]
28. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):295-301. PubMed ID: 9568994
[TBL] [Abstract][Full Text] [Related]
29. [Hemagglutination titer of gamma-globulin preparations for intravenous use against OEP (original endotoxin protein), protease and elastase of Pseudomonas aeruginosa (author's transl)].
Yamashita N; Jozaki K; Iwata S; Iwasaki Y; Sunakawa K
Kansenshogaku Zasshi; 1981 Sep; 55(9):637-41. PubMed ID: 6172525
[No Abstract] [Full Text] [Related]
30. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A.
Klinger KW; Shuster CW
Infect Immun; 1984 Mar; 43(3):912-9. PubMed ID: 6421741
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterizations of a novel recombinant scFv antibody against exotoxin A of Pseudomonas aeruginosa.
Shadman Z; Farajnia S; Pazhang M; Tohidkia M; Rahbarnia L; Najavand S; Toraby S
BMC Infect Dis; 2021 Mar; 21(1):300. PubMed ID: 33761869
[TBL] [Abstract][Full Text] [Related]
32. The role of proteases and exotoxin A in the pathogenicity of Pseudomonas aeruginosa infections.
Wretlind B; Pavlovskis OR
Scand J Infect Dis Suppl; 1981; 29():13-9. PubMed ID: 6797058
[TBL] [Abstract][Full Text] [Related]
33. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.
Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H
Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902
[TBL] [Abstract][Full Text] [Related]
34. Reliable enzyme-linked immunosorbent assay systems for pathogenic factors of Pseudomonas aeruginosa alkaline proteinase, elastase, and exotoxin A: a comparison of methods for labeling detection antibodies with horseradish peroxidase.
Shigematsu T; Suda N; Okuda K; Fukushima J
Microbiol Immunol; 2007; 51(12):1149-59. PubMed ID: 18094533
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
Blackwood LL; Stone RM; Iglewski BH; Pennington JE
Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
Klinger JD; Straus DC; Hilton CB; Bass JA
J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
[TBL] [Abstract][Full Text] [Related]
37. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization.
Pollack M; Prescott RK
J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576
[TBL] [Abstract][Full Text] [Related]
38. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
Stanislavsky ES; Dmitriev BA; Lányi B; Joó I
Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
[No Abstract] [Full Text] [Related]
39. Effect of passive immunotherapy on murine gut-derived sepsis caused by Pseudomonas aeruginosa.
Matsumoto T; Furuya N; Tateda K; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1999 Aug; 48(8):765-770. PubMed ID: 10451000
[TBL] [Abstract][Full Text] [Related]
40. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
